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Ligand-Independent Activation of the EGFR by Lipid
Raft Disruption
Sylviane Lambert1,2, Dina Vind-Kezunovic1, Susanna Karvinen1 and Robert Gniadecki1
Normal and immortalized keratinocytes demonstrate large aggregates of lipid rafts, detectable by membrane
staining with fluorescently tagged cholera toxin (CTx). As lipid rafts are known to regulate the function of many
surface receptors, we wished to investigate their impact on the EGFR in HaCaT cells. When rafts were disrupted
by cholesterol sequestration with methyl-b-cyclodextrin (MbCD) or filipin III, EGFR rearranged into
approximately micrometer large clusters outside the CTxbright raft aggregates. These clusters contained high
concentrations of activated, tyrosine-phosphorylated EGFR exhibiting greatly reduced mobility in the
fluorescence recovery after photobleaching experiments. EGFR activation led to the stimulation of extracellular
signal-regulated kinase 2, the phosphorylated form of which translocated to the nucleus and stimulated growth
of the MbCD-treated cells. Experiments with the specific antagonistic antibody proved that the activation of
EGFR by lipid raft disruption occurred without the participation of the ligand. We hypothesize that cholesterol
depletion leads to the release of EGFR from the damaged rafts into the small confined areas of the membrane,
where the receptor molecules are likely to be spontaneously activated owing to a very high density and/or
separation from the inhibitory factors remaining in the surrounding portions of the membrane.
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INTRODUCTION
Cholesterol is an essential component of the plasma
membrane and has been implicated in the regulation of
membrane fluidity, permeability, and receptor function
(Brown and London, 1998; Gimpl et al., 2002; Xu et al.,
2005). The concentration of cholesterol is focally increased
in plasmalemmal microdomains called lipid rafts. These
structures are also enriched in sphingolipids and gangliosides
and act as molecular platforms for various receptor and non-
receptor proteins (Simons and Ikonen, 1997; Simons and
Toomre, 2000; Pike, 2003). Disruption of lipid rafts can be
achieved by a cholesterol-depleting agent, methyl-b-cyclo-
dextrin (MbCD) (Keller and Simons, 1998; Rodal et al., 1999),
and it has been shown that this compound affects the
function of a variety of membrane receptors (reviewed by
Pike, 2005). Different studies have shown that the function of
EGFR depends on its association with lipid rafts, and raft
disruption by MbCD leads to an increase in both basal and
EGF-stimulated receptor autophosphorylation (Roepstorff
et al., 2002; Jans et al., 2004; Takebayashi et al., 2004; Pike,
2005).
Owing to the importance of EGFR for growth, survival,
and cell migration in the epidermis, we decided to study how
membrane cholesterol regulates EGFR activity in the kerati-
nocyte cell line HaCaT. We and others have previously
shown that both normal keratinocytes and HaCaT cells
demonstrate a very high content of clustered lipid rafts
enriched in GM1 ganglioside (Gniadecki and Bang, 2003;
Jans et al., 2004), which are detectable by labeled cholera
toxin B subunit (CTx) (Wolf et al., 1998). We show here that
raft destruction by cholesterol depletion releases EGFR from
the rafts into small, circumscribed areas in the plasma
membrane where the receptors become activated and further
stimulate cell proliferation via extracellular signal-regulated
kinase 2 (ERK2).
RESULTS
Cholesterol depletion disrupts lipid rafts and induces EGFR
clustering
Cells were starved in serum-free Dulbecco’s minimal
essential medium (DMEM) for 2 hours before the experiment
to avoid receptor activation by the growth factors present in
fetal calf serum. Cells were formalin or acetone fixed, and
stained with EGF-Alexa 555 or anti-EGFR antibody (both E30
and LA1) in combination with CTx-FITC. All three staining
techniques revealed the presence of EGFR both in the
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CTxbright lipid raft aggregates and in lesser quantities in the
bulk membrane (Bang et al., 2005) in control cells (Figure 1a
and c). In contrast, in the MbCD-treated cells, EGFR was
mainly found within the 0.5–3 mm large clusters, mostly in the
apical part of the membrane (Figure 1a and d). The same
effect of cholesterol depletion was detected in cells that were
labeled with EGF-Alexa 555 (at 41C to avoid ligand-induced
clustering) before exposure to MbCD (Figure 1b). The anti-
EGFR or EGF-Alexa 555-labeled foci did not overlap with the
CTxbright regions (Figure 1c and d). The formation of EGFR
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Figure 1. Clustering of EGFR after cholesterol depletion. (a) Cultured HaCaT cells were incubated with 1% MbCD or DMEM (control) for 30 minutes at 371C,
fixed in paraformaldehyde, and stained with the mouse E30 anti-EGFR antibody followed by anti-mouse Texas red secondary antibody (red) and CTx-FITC
(green). Comparable results were obtained in experiments where the E30 antibody was substituted with LA1 antibody (not shown). (b) The cells were labeled
with EGF-Alexa 555 (red channel) for 30 minutes at 41C, washed, and incubated in 1% MbCD or DMEM (control) for 30 minutes. The cells were acetone fixed
and counterstained with CTx-FITC (green channel). EGFR clustering was also seen when MbCD-treated cells were stained with EGF-Alexa 555 and CTx-FITC
after acetone fixation. (c) The cells were treated as in (b) and scanned in confocal microscope to obtain linear intensity histograms representing the fluorescence
of EGF-Alexa 555 (red curve) and CTx-FITC (green curve). The X-axis represents the distance along which the measurement was taken. In the control cells, the
high-intensity green fluorescence denotes CTxbright lipid raft aggregates (LRA). Note that in control cells, the green and red fluorescence intensities are spatially
correlated and that after MbCD treatment, the large LRA disappear and the intensity of EGF-Alexa 555 increases also in the regions poorly labeled with CTx
(vertical arrows). (d) Cells were treated with 1% MbCD for 30 minutes as described above, scanned after staining with EGF-Alexa 555 (left) or anti-EGFR LA1
antibody (right), and the images were reconstructed in the Z-plane. The Left lower image represents reconstruction along the magenta line at the level of the
basal membrane. Images in the right column represent Z-axis reconstruction of the whole cell. Note that the bright red clusters representing EGFR (arrows) do
not colocalize with CTx-FITC (green) and are present either at the margins of CTxbright regions or in the regions unlabeled by CTx. (e) Adherent cells were stained
with E30 anti-EGFR followed by a secondary anti-mouse FITC conjugate and scanned immediately by laser scanning cytometry to determine the membrane
expression of EGFR. The red line represents control, untreated cells and the black line cells treated with 1% MbCD for 30 minutes, as in (a).
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clusters involved receptors already present on the cell
surface, as the cytometric analysis of the total surface EGFR
did not show any significant differences between control and
MbCD-treated cells (Figure 1e).
Restricted lateral mobility of EGFR within the membrane
clusters
When the living MbCD-treated cells were observed over a
longer time period (20 minutes), we noted that the EGFR
clusters were stable structures. Having ruled out the
possibility that the clusters simply represent endocytotic
vesicles (see Figure 1d), we asked whether this could be due
to the restricted movement of the receptor molecules out of
the clusters. To differentiate between these two possibilities,
we performed fluorescence recovery after photobleaching
(FRAP) experiments in which a narrow area in the membrane
of control and MbCD-treated cells was photobleached and
the fluorescence recovery, proportional to the lateral move-
ment of the molecules, was calculated (Figure 2). In
concordance with our previous data (Vind-Kezunovic D,
Gniadecki R (2005) Molecular mobility in lipid rafts in
keratinocytes: implications for the regulation of membrane
receptor activity (abstract no. 410). J Invest Dermatol 124
(Suppl 4):A69), the fluorescence recovery of both CTx-FITC
and EGF-Alexa 555 was significantly lower in the CTxbright
areas than in the bulk membrane (Figure 2). This is consistent
with the fact that the CTxbright portions of the membrane are
composed of clustered lipid rafts characterized by a higher
molecular order of the lipid compartment (the liquid ordered
state) (de Almeida et al., 2003; Sinha et al., 2003). Similar to
the recently published report (Kwik et al., 2003), we observed
a decrease in fluorescence recovery in MbCD-treated cells,
both in the CTxbright and CTxdim regions (Figure 2b).
However, the lowest recovery was noted when whole EGFR
clusters were photobleached in MbCD-treated cells (Figure
2a, lower row). In this case, the recovery was much lower
than that obtained in the CTxbright portions of the membrane
also containing unclustered EGFR (16.2%72.1 (SE) vs
30.2%72.1, Po0.05; Figure 2c). Similarly, a very low
recovery was also seen in cells in which the EGFR clusters
were produced by incubation with the labeled ligand (Figure
2c). This observation indicates that receptor clusters in the
MbCD-treated cells behaved similar to the receptors acti-
vated by the natural ligand.
Cholesterol depletion activates ERK2 and cell growth via EGFR
To elucidate whether the EGFR clusters in the membranes of
cholesterol-depleted cells contained activated receptors, we
employed a specific antibody against Tyr1173, which has
previously been shown to detect activated EGFR (Gill et al.,
1987; Westover et al., 2003). Figure 3a and b demonstrate
the presence of Tyr1173-phosphorylated EGFR (pEGFR)
within EGFR clusters. This was further confirmed by Western
blot analysis of the extracts from the MbCD-treated cells. We
found a time-dependent activation of EGFR starting at
approximately 1 hour after MbCD (Figure 3c). It was noted
that although the maximal ERK2 activation was achieved
approximately after 1 hour treatment with MbCD, the
quantity of pEGFR increased steadily and stabilized after
approximately 3 hours of MbCD treatment.
ERK1/2 are involved in the downstream EGFR signaling
pathway in response to EGF (Stoll et al., 2002) and
cholesterol depletion (Furuchi and Anderson, 1998; Chen
and Resh, 2002). We found an increase in the phosphorylated
form of these kinases, mostly the ERK2 isoform, after MbCD
treatment (Figure 3c and d). The kinetics of ERK2 activation
peaked at approximately 1 hour after MbCD exposure and
declined during the following 6 hours and was similar to that
induced by exogenous EGF (not shown).
To investigate the dependency of ERK2 on EGFR, we have
applied a specific inhibitor of EGFR tyrosine kinase,
tyrphostin AG1478. As shown in Figure 4a, MbCD was
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Figure 2. Lateral movement of EGFR in cholesterol-depleted cells. Cells
were stained with CTx-FITC (green) and EGF-Alexa 555 (red) and imaged in
confocal microscope. Subsequently, a 1.2-mm-wide strip was photobleached
through the CTxbright and CTxdim regions of the membrane and fluorescence
recovery was calculated as described in Materials and Methods. Images
in (a) (upper row) show an MbCD-treated cell before photobleaching,
immediately after (0 second), and 370 seconds after photobleaching. The
lower row shows lack of FRAP of single EGFR clusters in MbCD-treated cells.
(b) Fluorescence recovery (mean7SEM, n¼ 6) for CTx and EGFR in control
cells and after MbCD treatment. Note that EGF-Alexa 555 and CTx-FITC
fluorescence recoveries are significantly lower in the CTxbright than in the
CTxdim areas, both in the control cells and the MbCD-treated cells (Po0.05,
t-test). MbCD treatment causes a further decrease in recovery (*Po0.05,
t-test). (c) Time-resolved fluorescence recovery curves for EGF-Alexa 555 in
the CTxbright regions in control cells (J), MbCD-treated cells (n), and for
single EGFR clusters in control (&) and MbCD-treated cells (B). There is a
significant difference at Po0.0001 between any pair of curves (F-test) except
for B and &. All symbols show mean values (n¼6 cells) with SD.
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unable to activate ERK2 in cells pretreated with AG1478. We
have also considered the possibility that the effects of MbCD
were due to a mechanism other than cholesterol depletion
and we have therefore used an unrelated compound, filipin
III, that disrupts rafts by forming intramembranous complexes
with cholesterol. As shown in Figure 4b, filipin III was able to
activate EGFR/ERK2 signaling, confirming the hypothesis that
lipid raft disruption was a cause of receptor activation.
We hypothesized that activation of ERK2 by MbCD would
lead to increased cell proliferation. Indeed, low concentra-
tions (0.1–0.5%) of MbCD increased HaCaT cell growth
(Figure 5). Higher MbCD concentrations (X1%) or prolonged
incubation for 412 hours inhibited cell proliferation and
were lethal to the cells. The involvement of EGFR in the
MbCD-induced stimulation of growth was confirmed by the
fact that AG1478 and mitogen-activated protein kinase/ERK
kinase inhibitor PD98059 reduced cell growth after choles-
terol depletion (Figure 5d). However, when cells pretreated
with MbCD were stimulated by exogenous EGF, their
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Figure 3. Activation of EGFR–ERK2 signaling in MbCD-treated cells. (a) Confocal images of the cells prelabeled with EGF-Alexa 555 (red channel) and
subsequently treated with 1% MbCD as in Figure 1a. After acetone fixation, the cells were stained with rabbit anti-pEGFR followed by the secondary anti-rabbit
FITC-conjugated antibody (green channel). Note colocalization of the EGFR clusters and pEGFR. A reverse experiment where cells were treated with 1% MbCD,
acetone fixed, and stained with anti-pEGFR antibody and EGF-Alexa 555 yielded an identical result (not shown). (b) Staining of MbCD-treated and acetone-fixed
cells with anti-pEGFR revealing spatial separation between pEGFR clusters (Texas red staining, red) and CTx-labeled areas (green). (c) Extracts from control
and MbCD-treated cells were analyzed by Western blot. Each membrane was cut along the 70 kDa line; the upper part was probed with the antibody
against pEGFR and anti-EGFR (E30 antibody), whereas the lower part with the antibodies recognizing activated ERK1/2 (monoclonal mouse anti-pERK1/2)
and total ERK (polyclonal, rabbit). The experiment was repeated at least four times with a similar result. (d) The amount of phosphorylated ERK1 and ERK2
was calculated from the Western blot shown in (c) as a fraction of the total form and expressed as percent of the control (Ctl 1 hour, cells incubated for 1 hour
in DMEM).
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Figure 4. Cholesterol depletion activates ERK2 in an EGFR-dependent
manner. Cells were pretreated with the specific EGFR tyrosine kinase
inhibitor AG1478 (1 mM, 15 minutes) and incubated with 1% MbCD (a) or
2mg/ml filipin III (b) for 1 or 1.5 hours in the presence of the inhibitor. Cell
lysates were analyzed by Western blot as in Figure 3c.
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mitogenic response was lower than that of the control, not
depleted cells (Figure 5e).
It is well known that ERK1/2 migrates into the nucleus, where
it activates several transcription factors involved in proliferation
and differentiation (Chen et al., 1992; Lenormand et al., 1998).
Also in MbCD-treated cells, fraction of pERK1/2 (approximately
25%) appeared in the nucleus, whereas in the control cells,
pERK1/2 was localized mainly in the cytoplasm (Figure 6).
EGFR activation is ligand independent in cholesterol-depleted
cells
We considered the possibility that even in the absence of
exogenous ligand, MbCD treatment could release membrane-
anchored EGFR ligands via the activation of metalloproteinases
(Prenzel et al., 1999). We have therefore used a neutralizing
antibody that sterically blocks the ligand-binding site of EGFR
and prevents the ligand-induced activation of EGFR. Cells were
pretreated with the LA1 neutralizing antibody followed by MbCD
(or 5ng/ml EGF for positive control). As shown in Figure 7, EGFR
could be Tyr1173 phosphorylated by MbCD even in the
presence of the LA1 antibody, but the antibody treatment
prevented EGFR phosphorylation in the EGF-treated cells.
DISCUSSION
This work indicates that in HaCaT cells, the EGFR is activated
in a ligand-independent manner solely by cholesterol
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Figure 5. Moderate cholesterol depletion stimulates cell growth via EGFR but impairs the mitogenic response to EGF. (A–C) Cells were incubated with 0–2% MbCD
for 2–24 hours and pulse-labeled with BrdU for 30minutes at the end of the incubation. The contribution of the BrdUþ cells (shown in the insets as red events on the
dot-plot charts) is highlighted in red on the DNA histograms in (a) (control cells, 0% MbCD, 4 hours) and (b) (0.5% MbCD, 4 hours). The proportion of BrdUþ cells
after treatment with different concentrations of MbCD for different periods (n¼ 3, mean7SD) is shown in (c). *Significant increase in the proportion of BrdUþ cells
compared to cells not treated with MbCD (Po0.01, t-test). (d) Cells were pretreated for 15 minutes with the specific EGFR tyrosine kinase inhibitor AG1478 (1mM), the
specific mitogen-activated protein kinase/ERK kinase inhibitor PD98059 (2mM), or the vehicle (0.1% DMSO) and treated with the indicated concentrations of MbCD in
the presence of the inhibitor or vehicle for additional 4 hours. Cells were washed and cultured for a total of 24 hours. Cell number was assessed by staining with
methylene blue and expressed in absorbance units. The values represent mean percent of change þ SD compared to control cells treated with the relevant kinase
inhibitor (or DMSO) but without MbCD (values4100% mean stimulation of growth). MbCD caused a statistically significant increase in cell number at concentrations
0.1 and 0.5% (*Po0.01, t-test), but caused cell death at the concentration of 1% (E Po0.01, t-test). Cell numbers in the groups treated with MbCD with PD98059 or
AG1478 were lower (#Po0.001, t-test) than in the corresponding MbCD-treated cells that had not been pretreated with these blockers. (e) Cells were incubated with
the indicated concentrations of MbCD (0–0.5%) for 1 hour before the addition of EGF for 4 hours. Absorbance was measured 24hours after MbCD treatment as in (d)
and the results are expressed as percent of the values obtained for cells not stimulated with EGF. Bars show mean values with SD from three independent experiments.
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depletion from the lipid rafts. Further, the data show that in
cholesterol-depleted cells, the activated EGFR causes a
downstream ERK2 activation and migration into the nucleus,
which translates into a growth stimulatory signal for the cells.
Although this report is the first one to describe the
activation of EGFR–ERK signaling axis by raft disruption in a
keratinocyte cell line, cholesterol-dependent phosphoryla-
tion of EGFR has been observed in other cell lines (Chen and
Resh, 2002; Pike and Casey, 2002; Jans et al., 2004). It is
important to note that recent data suggest the existence of an
identical mechanism of EGFR activation in normal human
keratinocytes in culture (Poumay Y, Ameels H, Jans R,
Mathay C, Lambert S, Gniadecki R (2005) The EGF receptor
of normal primary cultured keratinocytes is activated by a
depletion of membrane cholesterol but is not responsible for
alteration of the cell phenotype. Poster no. 15, 35th Annual
European Society for Dermatological Research (ESDR)
Meeting, 22–24 September 2005, Tu¨bingen, Germany;
http://www.esdr.org/pn/html/esdr/pdf/jidfinalabs.pdf). Although
other receptors such as Fas (Hueber et al., 2002; Gniadecki,
2004) and PDGFR (Matveev and Smart, 2002) may also be
activated by raft disruption, this is a receptor- and cell-
specific phenomenon. For example, Fas in non-keratinocytes
(Hueber et al., 2002), the insulin receptors, or T-cell receptors
are inhibited by MbCD treatment (Parpal et al., 2001;
Karlsson et al., 2004), whereas tumor necrosis factor receptor
I signaling to NF-kB is independent of lipid raft integrity in
HaCaT cells (Lisby S, Gniadecki R, unpublished data).
Several hypotheses have been developed to explain the
surprising fact of EGFR activation after lipid raft disruption. It
is generally believed that raft disruption by cholesterol-
sequestering agents like MbCD causes migration of the
receptors to the surrounding, non-raft portions of the
membrane (Pike, 2005). This evidence is circumstantial
because the very small size of the rafts precludes direct
microscopic observations of receptor movement. The asso-
ciation between proteins and lipid rafts has mostly been
investigated by biochemical methods where detergent-
insoluble fractions of membrane were separated by ultra-
centrifugation (Brown and London, 1998). However, in the
presence of detergents, the membrane structure may reorga-
nize to generate new raft domains that do not exist in the
intact cells. The model of HaCaT cell employed in this study
provided a unique possibility of observing the relationship
between EGFR and the large clusters of CTx-FITC-labeled
lipid rafts. In concordance with the membrane fractionation
data (Mineo et al., 1999), we found that a portion of EGFR
was associated with CTxbright raft aggregates.
A striking finding was that raft disruption by MbCD caused
a general decrease in the lateral mobility of EGFR and
formation of very large clusters, which contained the
activated, phosphorylated form of EGFR. The experiments
in which single clusters were photobleached demonstrated
only a minuscule fluorescence recovery, suggesting that the
EGFR molecules were functionally isolated from the CTxbright
surrounding portions of the membrane. Thus, lipid raft
disruption causes a rearrangement of EGFR in the membranes
to form the micrometer large clusters containing the rather
immobile EGFR molecules. These EGFR macrodomains may
provide a particularly permissive environment enabling a
ligand-independent activation. Evidence exists that EGFR
may be activated spontaneously and EGF signaling may
propagate laterally without the participation of the ligand in
cells with high concentrations of surface EGFR (Sawano et al.,
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Figure 6. pERK1/2 is translocated into the nucleus after MbCD treatment.
Control (a) and MbCD (1%, 1 hour)-treated cells (b) were fixed and stained
with mouse anti-pERK1/2 antibody followed by anti-mouse Texas red-labeled
secondary antibody. Fluorescence intensities were calculated from confocal
images of the MbCD-treated cells, the control, untreated cells (Con), and the
EGF-treated cells (positive control, 5 ng/ml EGF for 1 hour) for the cytoplasmic
and nuclear regions (n¼ 9 cells for each group) and shown in (c) as
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Figure 7. EGFR activation by MbCD is ligand independent. Cells were
preincubated with the neutralizing anti-EGFR antibody (clone LA1), and
treated with 1 or 2% MbCD for 1 hour. The negative controls were incubated
with the serum-free DMEM, whereas the positive control cells were treated
with 5 ng/ml of EGF for the same period of time. Cell extracts were analyzed
by Western blot with the antibodies recognizing pEGFR, pERK1/2, or ERK1/2,
as in Figure 3c.
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2002). It is conceivable that a very high concentration of
EGFR molecules on a very restricted area within the clusters
permits for a spontaneous activation of the receptor.
Our FRAP experiments also showed that bleaching of a
portion of the CTxbright region where EGFR clusters were
confluent yielded a higher degree of fluorescence recovery
than when single, isolated EGFR clusters were bleached. This
indicates that EGFR is more likely to migrate from cluster to
cluster rather than out to the surrounding plasma membrane.
Thus, according to the theory of lateral transmission of EGF
signaling (Verveer et al., 2000; Reynolds et al., 2003), the
activated EGFR may propagate the signal to other areas,
possibly even to those where receptor density is too low to
initiate spontaneous autophosphorylation. It should also be
noted that emigration of EGFR from the rafts might cause a
physical separation of the receptor molecules from some
inhibitory factors, such as the recently discovered caveolin-1/
CD82/protein kinase C-a membrane complex (Paller AS, Sun
P, Go L, Wang X (2005) Ganglioside forms a caveolin-1/
CD82/PKC-a/EGFR complex to inhibit EGFR signalling
(abstract). J Invest Dermatol (Suppl) 124:A93). Such large
multiprotein complexes stabilize lipid rafts (Nichols, 2005)
and raft destruction is likely to cause their dissipation.
Another important and novel finding is that the ligand-
independent EGFR activation by raft disruption provides a
mitogenic signal for HaCaT cells. Western blot experiments
demonstrated an activation of the EGFR–ERK axis with the
preferential involvement of ERK2 isoform and its transloca-
tion from the cytoplasm to the nucleus. The whole EGFR/
ERK2 pathway was relevant for cell growth, as inhibition of
either EGFR by AG1478 (which specifically blocks EGFR but
not the closely related ErbB2 at the used concentration) or
ERK led to cessation of cell proliferation in response to
MbCD. Surprisingly, the cholesterol-depleted cells were
unable to react to mitogenic stimuli from exogenous EGF.
This impairment was not due to the downregulation of
receptor density or to impaired activation of ERK1/2 by EGF
in MbCD-treated cells, as there was no difference in the level
of EGF-induced ERK activation in control and MbCD
(0.5–1%)-treated cells (not shown).
The final outcome of cholesterol depletion depends on the
degree and length of depletion. It is well known that chronic
cholesterol depletion is incompatible with cell growth (Xu
et al., 2005) and may result in cell death (Bang et al., 2005),
activation of death receptors (Gniadecki, 2004), or cell
differentiation via p38 (Jans et al., 2004). Moreover, MbCD
seems to induce an autophagy-like condition (Gniadecki R,
Wojewodzka U, Eefsen R, Gajkowska B (2005) Disruption of
lipid rafts results in the caspase-independent, autophagic cell
death. Poster no. 87, European Life Scientist Organization
(ELSO) Meeting, Dresden, Germany; http://www.elso.org/
index.php?id=abstrlist2005&lid=334) resulting in mitotic
quiescence. In cells incubated with MbCD for prolonged
periods of time, these inhibitory pathways would eventually
dominate and cause growth cessation.
In summary, our paper provides a new paradigm of the
ligand-independent activation of EGFR solely by cholesterol
depletion and raft disruption. Taking into account the central
involvement of EGFR and related receptors in psoriasis (Elder
et al., 1989; Cook et al., 2004) and carcinomas (Mendelsohn
and Baselga, 2000; Yarden, 2001; Normanno et al., 2005), our
data may shed new light on the pathogenesis of these diseases.
Deregulation of cholesterol metabolism is a recently recog-
nized feature of psoriasis (Rocha-Pereira et al., 2001; Reynoso
et al., 2003) and tumor cells contain high levels of cholesterol
and undergo apoptosis in response to statins (Jakobisiak and
Golab, 2003). Our laboratory is currently examining the
relevance of these findings for growth and death receptor
signaling in pathologically altered keratinocytes.
MATERIALS AND METHODS
Chemicals and antibodies
Rabbit polyclonal anti-ERK1/2 and mouse monoclonal anti-phos-
pho-ERK1/2 (Thr202/Tyr204) were purchased from Cell Signaling
(Beverly, MA). Rabbit polyclonal anti-phospho-EGFR (Tyr1173) was
from Biosources (Camarillo, CA) and mouse anti-EGFR from
DakoCytomation (clone E30, Glostrup, Denmark). Mouse neutraliz-
ing monoclonal anti-EGFR (clone LA1) was from Upstate (Lake
Placid, NY). EGFR inhibitor tyrphostin AG1478, mitogen-activated
protein kinase/ERK kinase inhibitor PD98059, MbCD, filipin III, CTx-
FITC, and DMSO were from Sigma-Aldrich (St Louis, MO). EGF was
from Gibco BRL (Gaithersburg, MD) and EGF-Alexa 555 was from
Molecular Probes (Eugene, OR).
Cell culture and cholesterol depletion
HaCaT cell line, a spontaneously immortalized human skin
keratinocyte cell line (Boukamp et al., 1988), was initially obtained
from Dr M.R. Pittelkow (Mayo Clinic, Rochester, MI) and maintained
in DMEM (Gibco BRL) supplemented with 10% fetal calf serum
(Gibco BRL) in a humidified incubator with 5% CO2 at 371C. Before
treatments, cells were switched to serum-free DMEM and incubated
with the indicated concentrations of MbCD dissolved in DMEM at
371C. For the experiments with filipin III (2 mg/ml), AG1478 (1 mM),
and PD98059 (1–2mM), the control cells were incubated with the
same amount of the vehicle (DMSO). These blockers do not cause
any appreciable death of HaCaT cells at the above concentrations
(Trypan blue assay).
Western blotting
Whole-cell lysates were prepared from HaCaT cells grown in 60 mm
Petri dishes as described previously (Jans et al., 2004). Proteins were
separated by SDS-PAGE on 7.5 or 10% gels, transferred onto a
nitrocellulose membrane (Bio-Rad, Philadelphia, PA) by vertical wet
electrotransfer, blocked for 1 hour at 41C with Li-Cor blocker
(Lincoln, NE), and incubated overnight with primary rabbit and
mouse antibodies at 41C. Secondary antibodies labeled with 700
IRDye (anti-rabbit) and 800IRDye (anti-mouse) (both obtained from
Li-Cor) were used for the detection with the infrared Odyssey
imaging system (Li-Cor).
Proliferation assays
The cells were seeded on 24-well plates at 125,000 cells/well and
allowed to adhere overnight. Cells were then treated with MbCD for
5 hours in serum-free DMEM, washed once with PBS, and incubated
overnight in fresh DMEM containing 1% fetal calf serum. Then, the
cells were washed twice with PBS, fixed with formaldehyde, and
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stained with 0.1% aqueous methylene blue solution for 15 minutes
(Espevik and Nissen-Meyer, 1986). The dye was subsequently
extracted with 0.1 M hydrochloric acid and absorbance was
measured at 595 nm (Ultraspec III spectrophotometer, Pharmacia,
Uppsala, Sweden). Bromodeoxyuridine (BrdU) incorporation experi-
ments were performed as described previously (Gniadecki and Bang,
2003) using murine anti-BrdU antibody (DakoCytomation) followed
by FITC-labeled secondary anti-mouse antibody and propidium
iodide for laser scanning cytometry (Thorn et al., 2001).
Laser scanning cytometry
Laser scanning cytometry was used for quantitative determination of
integrated fluorescence in the cells, as described previously (Thorn
et al., 2001; Gniadecki and Bang, 2003). For cell cycle analysis, the
fluorescence was acquired in the green (BrdU) and red (propidium
iodide) channels, enabling simultaneous cell cycle analysis (Thorn
et al., 2001). The baseline fluorescence level was determined by
using cells stained with the secondary, FITC-conjugated antibody
only. Proportions of BrdUþ cells were calculated using the feature of
the Wincyte software (CompuCyte, Cambridge, MA). To calculate the
total surface expression of EGFR, the adherent cells were stained with
mouse anti-EGFR (DakoCytomation) for 30 minutes at 41C followed
by anti-mouse FITC conjugate. Cells were contoured using forward
scatter as a parameter and integrated fluorescence recorded from
approximately 5,000 cells to construct fluorescence histograms.
Confocal laser scanning microscopy
Cells were grown on Lab-Tek chamber slides (Nunc, Roskilde,
Denmark), treated as described and stained after fixation with
acetone (10 minutes, room temperature) or 4% paraformaldehyde at
41C for 20 minutes (Gniadecki and Bang, 2003). For ERK1/2
immunocytochemistry, we found that the optimal conditions are
provided by a shorter paraformaldehyde fixation (4%, 5 minutes,
room temperature) followed by permeabilization with 1% Triton X-
100 (5 minutes, room temperature). Lipid raft aggregates were
labeled with CTx-FITC conjugate for 30 minutes at room tempera-
ture. For detection with secondary antibodies, we used Texas red-
labeled goat anti-mouse antibody (Jackson Laboratories, Bar Harbor,
ME) or FITC-conjugated polyclonal porcine anti-rabbit antibody
(DakoCytomation) for 30 minutes at room temperature. The samples
were imaged by Olympus IX70 confocal laser scanning microscope
using 488 and 568 nm excitation lines from an argon–krypton laser
(Olympus FluoView Confocal System). The average fluorescence
intensity was determined in the regions of interest using the
proprietary FluoView software in approximately 20 cells for each
experiment.
FRAP
Cells were cultured on four-well Lab-Tek chamber slides and kept in
DMEM without phenol red (Gibco BRL) or fetal calf serum
throughout the experiments. Control cells or cholesterol-depleted
cells (1% MbCD for 60 minutes at 371C) were stained with 0.5 mg/ml
EGF-Alexa 555 conjugate and 2.5 mg/ml CTx-FITC for 15 minutes at
41C. FRAP experiments were performed for a total of 15 minutes at
271C using the confocal microscope system described above. The
pre-bleaching image was obtained at 20% laser power using the
488 and 568 nm lines of the argon–krypton laser and  100 oil
objective (NA 1.30) for optimum resolution. Emitted fluorescence
was captured with 510–540 nm filter for FITC fluorescence and
585–640 nm filter for Alexa 555 fluorescence. Then a 13-pixel-wide
strip was irreversibly photobleached using 5–10 scans at 100% laser
power. Post-bleach images were captured at the same conditions as
the pre-bleach reference image at 30 second intervals for 15 minutes.
In each scan, the fluorescence intensities were calculated using the
FluoView software within the bleached and non-bleached part of
the cell. Florescence recovery was calculated as a proportion of the
initial fluorescence intensity and compensated for the background
bleaching of the sample due to repetitive scans using the following
formula:
fluorescence recovery ð%Þ ¼ ytu
xwt
100%
where u and wt are respectively pre- and post-bleaching fluores-
cence intensities outside the bleached area at time t, and x and yt are
respectively the pre- and post-bleaching fluorescence intensities in
the photobleached region at time t. Maximum fluorescence recovery
was extrapolated from the hyperbolic recovery curves fitted to the
experimental data using the GraphPad Prism 3.03 package
(GraphPad Software Inc., San Diego, CA). Total recovery was
defined as an extrapolated maximum of the hyperbolic curve at
infinity. Statistical differences in fluorescence recovery values were
calculated by t-test and differences between the whole recovery
curves were assessed using the F-test.
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